Search research articles
Contact Us
Filters
Showing results (51-60 of 60) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 60 results.
The Journal of Pharmacology and Experimental Therapeutics
|
January 11, 2015
CHF6001 I: a novel highly potent and selective phosphodiesterase 4 inhibitor with robust anti-inflammatory activity and suitable for topical pulmonary administration
Nadia Moretto, Paola Caruso, Raffaella Bosco, et al.
Journal of Medicinal Chemistry
|
June 10, 2024
Discovery, Multiparametric Optimization, and Solid-State Driven Identification of CHF-6550, a Novel Soft Dual Pharmacology Muscarinic Antagonist and β<sub>2</sub> Agonist (MABA) for the Inhaled Treatment of Respiratory Diseases
Laura Carzaniga, Ian D Linney, Andrea Rizzi, et al.
Journal of Medicinal Chemistry
|
December 5, 2017
Discovery and Optimization of Thiazolidinyl and Pyrrolidinyl Derivatives as Inhaled PDE4 Inhibitors for Respiratory Diseases
Laura Carzaniga, Gabriele Amari, Andrea Rizzi, et al.
Journal of Medicinal Chemistry
|
May 13, 2022
Design, Synthesis, and Biological Characterization of Inhaled p38α/β MAPK Inhibitors for the Treatment of Lung Inflammatory Diseases
Elisabetta Armani, Carmelida Capaldi, Valentina Bagnacani, et al.
Journal of Medicinal Chemistry
|
August 10, 2023
Optimization of M<sub>3</sub> Antagonist-PDE4 Inhibitor (MAPI) Dual Pharmacology Molecules for the Treatment of COPD
Andrea Rizzi, Gabriele Amari, Fausto Pivetti, et al.
Journal of Medicinal Chemistry
|
June 18, 2021
Discovery of M<sub>3</sub> Antagonist-PDE4 Inhibitor Dual Pharmacology Molecules for the Treatment of Chronic Obstructive Pulmonary Disease
Elisabetta Armani, Andrea Rizzi, Carmelida Capaldi, et al.
Journal of Medicinal Chemistry
|
January 10, 2014
Novel class of benzoic acid ester derivatives as potent PDE4 inhibitors for inhaled administration in the treatment of respiratory diseases
Elisabetta Armani, Gabriele Amari, Andrea Rizzi, et al.
Journal of Medicinal Chemistry
|
March 14, 2007
Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2)
Ilaria Peretto, Claudia Fossati, Giuseppe A M Giardina, et al.
Journal of Medicinal Chemistry
|
July 28, 2022
Discovery of Clinical Candidate CHF-6366: A Novel Super-soft Dual Pharmacology Muscarinic Antagonist and β<sub>2</sub> Agonist (MABA) for the Inhaled Treatment of Respiratory Diseases
Laura Carzaniga, Ian D Linney, Andrea Rizzi, et al.
Journal of Medicinal Chemistry
|
March 14, 2007
Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1)
Ilaria Peretto, Roberto Forlani, Claudia Fossati, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 60) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 60 results.
The Journal of Pharmacology and Experimental Therapeutics
|
January 11, 2015
CHF6001 I: a novel highly potent and selective phosphodiesterase 4 inhibitor with robust anti-inflammatory activity and suitable for topical pulmonary administration
Nadia Moretto, Paola Caruso, Raffaella Bosco, et al.
Journal of Medicinal Chemistry
|
June 10, 2024
Discovery, Multiparametric Optimization, and Solid-State Driven Identification of CHF-6550, a Novel Soft Dual Pharmacology Muscarinic Antagonist and β<sub>2</sub> Agonist (MABA) for the Inhaled Treatment of Respiratory Diseases
Laura Carzaniga, Ian D Linney, Andrea Rizzi, et al.
Journal of Medicinal Chemistry
|
December 5, 2017
Discovery and Optimization of Thiazolidinyl and Pyrrolidinyl Derivatives as Inhaled PDE4 Inhibitors for Respiratory Diseases
Laura Carzaniga, Gabriele Amari, Andrea Rizzi, et al.
Journal of Medicinal Chemistry
|
May 13, 2022
Design, Synthesis, and Biological Characterization of Inhaled p38α/β MAPK Inhibitors for the Treatment of Lung Inflammatory Diseases
Elisabetta Armani, Carmelida Capaldi, Valentina Bagnacani, et al.
Journal of Medicinal Chemistry
|
August 10, 2023
Optimization of M<sub>3</sub> Antagonist-PDE4 Inhibitor (MAPI) Dual Pharmacology Molecules for the Treatment of COPD
Andrea Rizzi, Gabriele Amari, Fausto Pivetti, et al.
Journal of Medicinal Chemistry
|
June 18, 2021
Discovery of M<sub>3</sub> Antagonist-PDE4 Inhibitor Dual Pharmacology Molecules for the Treatment of Chronic Obstructive Pulmonary Disease
Elisabetta Armani, Andrea Rizzi, Carmelida Capaldi, et al.
Journal of Medicinal Chemistry
|
January 10, 2014
Novel class of benzoic acid ester derivatives as potent PDE4 inhibitors for inhaled administration in the treatment of respiratory diseases
Elisabetta Armani, Gabriele Amari, Andrea Rizzi, et al.
Journal of Medicinal Chemistry
|
March 14, 2007
Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 2)
Ilaria Peretto, Claudia Fossati, Giuseppe A M Giardina, et al.
Journal of Medicinal Chemistry
|
July 28, 2022
Discovery of Clinical Candidate CHF-6366: A Novel Super-soft Dual Pharmacology Muscarinic Antagonist and β<sub>2</sub> Agonist (MABA) for the Inhaled Treatment of Respiratory Diseases
Laura Carzaniga, Ian D Linney, Andrea Rizzi, et al.
Journal of Medicinal Chemistry
|
March 14, 2007
Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1)
Ilaria Peretto, Roberto Forlani, Claudia Fossati, et al.
Page
of 6